Pharmacologic management of the myocardial infarction patient after discharge from the hospital.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000359:Aftercare; D000925:Anticoagulants / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001241:Aspirin / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D003329:Coronary Vasospasm / Q000517:prevention & control; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010974:Platelet Aggregation / Q000187:drug effects; D011379:Prognosis
D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D002316:Cardiotonic Agents; D002784:Cholesterol; D001241:Aspirin